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Abstract. Chronic exposure of differentiated avian
skeletal muscle cells in culture to the phorbol ester,
12-O-tetradecanoyl phorbol-l3-acetate (PMA), results
in the selective disassembly of sarcomeric structures
and loss of muscle-specific contractile proteins, leav-
ing cytoskeletal structures and their associated proteins
intact . We demonstrate here that these morphological
and biochemical changes are accompanied by dramatic
and selective decreases in the level of the mRNAs that
encode the contractile proteins . We measured the ef-
fects ofPMA on the transcriptional activity andmRNA
stability of four contractile protein genes (a-cardiac
and a-skeletal actin, cardiac troponin C [cTnC], and
myosin light chain if [MLClf]) and two nonmuscle
genes (ß-cytoplasmic actin and the glycolytic enzyme,
glyceraldehyde-3-phosphate dehydrogenase [GAPDH]) .
The transcriptional activity of the a-cardiac actin and
c hC genes dramatically decreased by 8 h after the
addition of PMA, while other muscle and nonmuscle
M
YOGENESTS follows a succession of developmental
stages, each characterized by distinct morphologi-
cal events andunique patterns of gene expression .
These stages are the establishment ofacommitted cell line-
age (determination), the expression of the muscle pheno-
type, which is marked, in part, by the accumulation of spe-
cific structural proteins (differentiation), and the further
specialization ofthe muscle cell through changes in muscle-
specific protein isoform expression (maturation) . Muscle de-
velopment in culture hasprovided aconvenient experimental
system in which to study some ofthe regulatory mechanisms
associated with these different stages (reviewed in Schwartz
and Stone, 1983 ; Crow, 1987) . In this system, committed
mesenchymal cells, called myoblasts, proliferate, then even-
tually withdraw from the cell cycle and differentiate . Dif-
ferentiation involves two separable phases : biochemical dif-
ferentiation, which results in the repression of subsets of
non-muscle genes and induction of muscle-specific gene ex-
pression (Schwartz and Rothblum, 1981 ; Hayward et al .,
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genes examined showed no change . Pulse-chase experi-
ments of in vivo labeled RNA showed significant re-
ductions in mRNA half-lifes for all the contractile pro-
tein mRNAs examined, while the half-lifes of ß-actin
and GAPDH mRNA were unchanged . All of the above
effects occurred under conditions in which cellular
protein kinase C (PKC) levels had been reduced by
>90% . The fact that many of the contractile protein
genes remained transcriptionally active despite the fact
that the cells were unable to accumulate their mRNAs
to any significant extent indicated that the treated cells
were still committed to skeletal muscle differentiation .
The selective changes in the stability of the contractile
protein mRNÀs suggest that the control of mRNA sta-
bility may be part of the normal regulatory program of
skeletal muscle differentiation and that this control
may be linked to the integrity of the contractile
apparatus and mediated by second messenger pathways
involving PKC activation .
1988) andmorphological differentiation, in which themono-
nucleated myoblasts fuse to form multinucleated myotubes .
The result is a rapidand extensive accumulation of different
muscle proteins and theirassembly into theorganized struc-
ture of the sarcomere . The specialization of the contractile
apparatus that is part oftheprocess ofmuscle maturation and
that involves the replacement of one contractile protein iso-
form for another occurs to only a limited extent in cultured
muscle cells . The cells are arrested atastage that closely re-
sembles early embryonicdevelopment in termsofisoform ex-
pression (Hayward andSchwartz, 1986 ; VanHorn andCrow,
1989) and are, presumably, awaiting signals that are nor-
mallyprovided during late embryonic life, hatching, orbirth.
Both the biochemical andmorphological differentiation of
muscle are sensitive to a variety of chemical and biological
agents . A number of these interfere directly or indirectly
with the ability of the calcium ion to act as an intracellular
messenger. Among these are the tumor promoting phorbol
esters, such as 12-O-tetradecanoyl phorbol-l3-acetate (PMA),
745which act in the cell to alter Cal+-sensitive, phospholipid-
dependent protein kinase C (PKC)' activity (Witters and
Blackshear, 1987; Bazzi and Nelsestuen, 1989) . A number
of groups have shown that PMA uncouples muscle cell dif-
ferentiation at various levels. For example, PMA stimulates
the replication of myoblasts, while inhibiting the biochemi-
cal differentiation and fusion of some myoblast populations
(Cohen et al ., 1977; Cossu et al., 1982; Croop et al., 1982;
Farzaneh et al., 1989). When added to fully differentiated
muscle cells, PMA leads to the separation of the I-Z-I com-
plex from the thick filaments and the subsequent formation
of 3-jm cortical actin-containing bodies composed of sarco-
meric a-actin and a-actinin. This is then followed by the
rapid degradation of the protein components of the thin fila-
ment and sometime later by the degradation of the proteins
of the thick filament (Lin et al., 1987). The specificity ofthis
effect for sarcomeric structures is exemplified by the fact that
(x-actin-containing thin filaments of the sarcomere are rap-
idly degraded in PMA-treated muscle cells, while ß- and
.y-actin-containing thin filaments of the cytoskeleton remain
intact. These effects of PMA are fully reversible upon its
removal (Lin et al., 1989) .
The above effects of PMA are of interest for a number of
reasons. The precise cataloging of the morphological events
that occur afterthe addition or removal of PMA has and will
continue to contribute significant insights into the processes
of sarcomere assembly, while the selectivity ofPMKs action
on the proteins of the contractile apparatus points to under-
lying control mechanisms that may serve to regulate the
cytoplasmic abundance of the contractile proteins and their
mRNAs. The well-established link between phorbol esters
and PKC activation further suggests that PKC could be the
intracellular messenger controlling this regulatory pathway.
We therefore sought to determine the level of gene regula-
tion at which PMA exerted its selective effects on the expres-
sion of muscle genes and the accumulation of their prod-
ucts. We examined whether PMA exerted a differential effect
on the level of muscle-specific mRNA accumulation and
whether that effect was due to changes in the transcriptional
activity of the genes encoding the contractile apparatus
and/or the stability of their encoded mRNAs. Furthermore,
since persistentactivation ofPKC by PMA has been reported
to accelerate the degradation of PKC and its loss from the
cell (Ballester and Rosen, 1985; Hepler et al., 1988), we
measured the changes in PKC accumulation and activity that
accompanied the changes in muscle-specific gene expres-
sion . Our results demonstrate thattreatment of primary avian
muscle cell cultures with PMA results in an extensive down-
regulation of cellular PKC levels and activity. Coincident
with or occurring after this decrease, the muscle-specific
mRNAs that encode sarcomeric proteins are selectively de-
stabilized and depleted from the cells. This accelerated loss
of muscle-specific mRNÀs was effectively blocked by inhib-
itors of RNA transcription and/or protein synthesis. The ef-
fects of PMA at the transcriptional level were even more se-
lective in that it inhibited the transcriptional initiation of
some muscle-specific genes while not affecting that of non-
muscle genes or other muscle-specific genes.
1. Abbreviationsusedinthis paper: AraC, cytosine arabinoside; MLC, myo-
sin light chain; PCR, polymerase chain reaction; PKC, protein kinase C.
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Materials andMethods
PrimaryMuscle CellCultures
Myoblasts were isolated from embryonic day 11 or 12 chicken embryonic
pectoral muscles as described previously (Hayward and Schwartz, 1986).
Cultures were established by either mechanical or enzymatic (trypsin)
means of cell dissociation. Both methods yielded the same results in all the
assays described below. Myoblasts were plated onto type I collagen-coated
plastic dishes at a cell density of 5 x 10°/cm2 and grown in Dulbecco's
Minimal Essential Media (DMEM, high glucose; Gibco Laboratories,
Grand Island, NY) supplemented with 10% preselected horse serum, 2 .5%
chick embryo extract, and 50 g,g/ml gentamycin. Media was then changed
every 48 h. 3-day-old cultures were treated for 24 h with 5 ;4M cytosine
arabinoside (AraC) to kill replicating cells. This treatment resulted in cul-
tures with <1% of the nuclei in cells other than myotubes.
Purification andAnalysis ofTotalCellular RNA
Total RNA was isolated from cell cultures by the guanidine isothiocyanate
procedure (Chirgwin et al., 1979) and fractionated on 1% agarose-form-
aldehyde gels after denaturation in methylmercury hydroxide. The RNA
was then electrophoretically transferred to Nylon membranes (Duralon;
Stratagene Cloning Systems, San Diego, CA) in IX Tris-acetate-EDTA
buffer at 6 V/cm for 4 h. The transferred RNA was then covalently cross-
linked to the Nylon by ultraviolet irradiation (120 mJ). The blots were pre-
hybridized at 45°C for 2-4 h in 50% formamide, 5x Denhardt's solution
(Sambrook et al., 1989), 0.5% SDS, 0.1% Nâ4PO7, 50 mM Tris HCI, pH
8, 0.5 mM EDTA, and 200 Ag/ml denatured salmon sperm DNA. Hybrid-
ization was performed in a buffer of the same composition containing 5 x
105 to 1 x 106 cpm/ml of radiolabeled probe.
cDNA Probes
cDNA probes were used to measure contractile protein mRNAs. For the
actins, DNA probes to the 3' untranslated regions of chicken a-skeletal,
«-cardiac, and ß-cytoplasmic actin were generated by polymerasechain re-
action (PCR) and then radiolabeled by the random priming method (Fein-
berg and Vogelstein, 1983). The fast alkali myosinlight chain (MLC) probe
was a randomly primeddouble-stranded300-bp EcoRI-Stylfragment of the
full-length chicken MLCIf cDNA, pGemFLCI (Crow, M., unpublished
data). This restriction fragment contained sequences from the 5' end ofthe
cDNA that reacted only with MLCIf and not with the related MLCIf
mRNA. The cardiac troponin C probe was a randomly primed double-
stranded 800-bp BamHI-HindIII fragment from the cDNA clone, p13 (Put-
key et al., 1987) and the GAPDH probe was a 1,200-bp Pstl fragment from
the chicken cDNA clone, pGAD28 (Dugaiczyk et al., 1983).
NuclearRun-on Transcription Assays
Relative transcriptional activity was assessed by nuclear run-on analysis.
MLCIf, cTNC, and GAPDH transcription were measured using the cDNA
probes described above. Actin genetranscription was measuredusing either
the full-length double-stranded cDNA probes pAC269 (Schwartz et al.,
1980) for skeletal a-actin and pACI for ß-cytoplasmic actin (Cleveland et
al., 1980) or a genomic clone, pAC7.5, for cardiac «-actin (Chang et al.,
1984). These probes were alkali denatured, neutralized, and 1-Ag portions
dot-blotted onto nylon membrane (Biotrans; ICN, East Hills, NY) in the
presence of 5.4x SSC. De novo nuclear RNA transcripts were assayed ac-
cording to theprocedure ofLinial and co-workers (1985). Nuclei from cul-
turedmusclecellswereisolatedbyhomogenizationoftheculturesin 10 mM
Tris-HCI (pH 7.4), 10 MM MgC12, 0.5% NP-40, and 0.5 M sucrose. The
released nuclei were pelleted and homogenized again in the above solution
without NP-40 and sucrose. The pellet was suspended in 4 pellet volumes
of storage solution (40% glycerol, 50 mM Tris-HCI [pH 8.3], 5 mM
MgCl2, and 0.1 M EDTA) and then frozen and stored in liquid nitrogen un-
til needed.
The run-on reaction consisted ofthawed or freshly prepared nuclei, run-
on buffer (5 mM Tris-HCI [pH 8.0], 2 .5 MM M9C12, 150 mM KCI, and
0.25 mM of ATP, GTP, and CTP) RNAse inhibitor, and 120 AC of
[32P]UTP (sp act >800 Ci/mmol; Amersham Corp., Arlington Heights,
IL) incubated at 30°C for 15 min. After incubation, DNA was removed by
DNAse 1 digestion (5 min at 37°C) and protein removed by proteinase K
digestion (30 min at 50°C) followed by phenol/chloroform extraction. Nu-
clear RNA was thenpartially cleaved anddenatured in0.2 M NaOH (10 min
746at 4°C), neutralized, and precipitated in 2.5 vol of ethanol. This labeled
RNA was added to a hybridization solution consisting of50% formamide,
1.5x SSPE (0.27 M NaCl, 0.015 M Na2PO4 [pH 7.0]),1.5 mM EDTA, 1%
SDS, 0.5% nonfat dry milk, and 0.2 mg/ml Fscherichia coli tRNA at N107
cpm/ml. Since sequence mismatches between the different actin isoform
mRNA species would be expected to result in a difference in Tm of only
10-13°C, hybridization was carried out at 50°C for 48 h. These stringent
conditions allowed for the use of full-length probes with minimal (<5%)
cross-hybridization (Chang et al., 1984). After hybridization, the mem-
branes werewashed at increasing stringencies, with a final wash in 2 x SSC,
1% SDS at 60°C. The dot blots were then rinsed at room temperature in
O.lx SSC, blotted dry, and exposed to x-ray film for 3-5 d at -70°C with
an intensifying screen. Autoradiographs were quantitated by soft-laser den-
sitometry after preexposing the x-ray film to an OD A540 of -0.1 as indi-
cated (Laskey and Mills, 1975) and were calibrated by eluting prebound
32P-labeled probe. Exposure of the film was limited so that no spot devel-
oped an absorbance >1.5 ODD. The autoradiograms shown in Fig. 2, 3,
and 5 were purposefully overexposed for publication.
MeasurementofmRNA Half-Lives
The rate ofmRNA degradation in PMA-treated and untreated (control) cul-
tures was measured by an extended pulse-chase method using [3H]uridine.
Total RNA in muscle cell cultures was labeled to nearequilibrium by a48-h
incubation in media containing 0.2 MCi/ml of [3H]uridine ([5,6 3H]uridine,
sp act 36.5-48 Ci/mmol; New England Nuclear, Boston, MA) starting on
day 3 after plating. Under these conditions, significant label could be incor-
porated into the most stable of the contractile mRNAs, e.g., MLCIf. A
100-mm culture typically incorporated N2 x 107 cpm or 7.4 x 107 dpm
(efficiency of counting = 27%) using this procedure. After labeling, the
cells were washed in DMEM and the [3H]uridine chased by incubating the
cells in DMEM containing 10 mM uridine and 10 mM cytidine for 2 h at
37°C. The media was then changed to that normally used to maintain mus-
cle cell cultures (see formulation above) with the addition of 1 mM uridine
and 1 mM cytidine. Cells were then maintained in this media for the dura-
tion of the experiment. No significant different was observed in the total
RNA or the specific activity of the radiolabeled RNA (cpm/lAg total RNA)
between control and PMA-treated cultures. The extreme stability of total
RNA (i.e., mostly rRNA) is consistent with previous reports of rRNA sta-
bility in exponentially growing cells (Abelson et al., 1974; Emerson, 1971)
and in, at least, one muscle cell line (Krauter et al., 1979).
Approximately 5 h after beginning thechase, PMA (75 ng/ml) was added
to experimental cultures, while only the vehicle for PMA (DMSO, 0.05%
final concentration) was added to control cultures. RNA was then isolated
from the cultures by the guanidine isothiocyanate procedure (Chirgwin et
al. [1979]) at various times after PMA was added. cDNA and PCR probes
were used to measure the relative level of specific tritiated mRNAs. These
probes were bound to nylon membrane (Duralon; Stratagene Cloning Sys-
tems)by UV cross-linking (254 nm, 120mJ), hybridized with tritiated RNA
at 1 x 106 cpm/ml, and washed as described for the nuclear run-on assays.
Thehybridized RNAwas then digested withpancreatic RNAse and exposed
to x-ray film. Background hybridization was assessed by binding of labeled
RNA topGEM3zf(+) and was on the orderof0.5-2ppminput RNA. Quan-
titation was performed either by laser densitometry or by direct counting
of tritiated RNA bound to the Nylon membrane following elution with 1N
NaOH. For quantitation by densitometry, the filter was treated with spray
scintillant (EnHance, New England Nuclear) and the x-ray film preflashed
to an optical density at 540 nm of -0.1. The amount of hybridized RNA
at any given time(t >0) during thechase was thenexpressed asa percentage
of hybridized counts at the time 4 h after initiation of the chase, which was
designated t = 0. Equivalent results were obtained with either method of
quantitation.
MeasurementofPKC Levels andActivity
The relative level of total PKC protein was determined by phorbol ester
binding as described previously (Neidel et al., 1983 ; Jaken, 1987). The
binding characteristics of 3H-phorbol 12, 13-dibutyrate [PdBul (18-20
Ci/mmol; Amersham Corp., Arlington Heights, IL) were first determined
by Scatchard analysis. Cells were plated onto collagen-coated 6-well plates
(Costar, Cambridge, MA) and nonmuscle cells were removed 3 d later by
AraC treatment (see above) . Increasing amounts of labeled PdBu in the
range of5-300 nM were incubated withcells at37°C for 30 min in DMEM
containing 10 mg/ml BSA. Preliminary experiments indicated that both
specificandnonspecific binding atthis temperaturewas linearup to 60 min.
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Nonspecificbinding was determined foreach concentrationoflabeled PdBu
as the amount of label that remained bound in the presence of 20 /AM unla-
beled PdBu. Specific binding was then determined by subtracting nonspe-
cific from total binding. The efficiency of scintillation counting under the
conditions of these experiments was -37%.
To determine the level of PKC expression by phorbol binding after
chronic PMA exposure, the cells were first extensively washed with media
and then incubated for 1 h in DMEM-BSA before labeled PdBu in DMEM-
BSA was added. This additional incubation period was necessary to remove
all traces of PMA, which could significantly interfere with the binding of
radiolabeled phorbol dibutyrate since, at equimolar concentrations, PMA
was an effective competitor of PdBu binding. If, after adding PMA for
1-2 h, the cells were extensively washed and incubated as described above,
x+85-90% of control (t = 0) PDBu binding could be retrieved. The failure
to actually retrieve 100% of the binding may reflect the failure to wash out
all traces of PMA or a PMA-mediated reduction in PKC levels occurring
during the period of the washes and incubations.
Changes in total PKC enzymatic activity were also measured to cor-
roborate the result of phorbol binding. Total activity was measured as the
sum of the activities from the cytoplasmic and particulate cell fractions,
which were prepared according to a modification of the procedure of Mar-
telly and co-workers (1989). Cells in a 100-mm dish were rinsed with
Hanks' solution, removed from the plate by scraping in 0.5 ml of 20 mM
Tris HCl (pH 7.5), 10 mM EGTA, 2 mM EDTA, 1 mM PMSF, and then
homogenized in a Dounce homogenizer. The homogenate was then spun at
100,000 g for 1 h to separate it into soluble and particulate fractions. The
supernatant or soluble fraction was diluted to aprotein concentration of0.5
mg/ml. The pellet was resuspended inthehomogenization buffer containing
0.1% Triton X-100 and then spun again. The resulting supernatant was
reserved as the particulate fraction. Both soluble and particulate fractions
were applied to DEAE-Sephadex columns (0.4 x 1 cm) equilibrated with
20 mM Tris HCl (pH 7.5), 0.5 mM EGTA, 0.3 mM EDTA, and 10 mM
0-mercaptoethanol. The columns were washed with 10 vol ofthe equilibra-
tion buffer and PKC eluted with 0-0.3 M NaCl gradient. Fractions (0.175
ml) were collected and 20-50 pl ofeach assayed for PKC activity. PKC ac-
tivity was assayed using a commercially available kit (Amersham Corp.),
which measures the incorporation of 32p from [32p]-yATP into a synthetic
peptidesubstrate for PKC. SpecificPKC activitywas expressedasthe differ-
ence between 32p incorporation in the presence and absence of exogenous
calcium, 40 mg/ml phosphatidylserine, and 10 ng/ml PMA.
Results
PMA SelectivelyRepressesSkeletal Muscle
Gene Expression in Cultured Myotubes
When the phorbol ester PMA was added to chicken muscle
cell cultures 4-5 d after plating, the cells failed to assemble
any organized sarcomeric structures. After 24 h of exposure
to PMA, the cells lost their elongated appearance and were
visible as "myosacs" with the multiple nuclei of the cells ag-
gregated in the center (see Fig. 1 and Lin et al., 1987) . The
effect of PMA on muscle-specific contractile protein gene
expression was then evaluated over time by Northernblotting
analyses. Fig. 2 shows the results of a typical analysis in
which total RNA isolated from PMA-treated and control
cultures was hybridized with radiolabeled probes to fast skel-
etal muscle MLClf, skeletal a-actin, cardiac a-actin, car-
diac troponin C, ß-cytoplasmic actin, and GAPDHmRNÁs.
Within 6 h after the addition of PMA, there was a large re-
duction in the steady-state accumulation ofthose mRNAs en-
coding the proteins ofthe thin filament (i.e., skeletal and car-
diac a-actins and cardiac troponin C); by 18 h, the level of
these mRNAs had decreased to N5-25% oftheir control val-
ues. The fast MLClf mRNA, which encodes a component
of the thick filament, showed a more gradual decline in con-
tent and was reduced to only -60% of its control value at
18 h. By 24 h, the level of this mRNA was 25 % of its control
and at 48 h, <5 %. In marked contrast, the mRNAs encoding
747Figure 1. Phase contrast photomicrographs of PMA-treated muscle
cell cultures. (A) Control cultures treated with vehicle (0.1%
DMSO) for 24 h . (B) Cultures treated for 24 h withPMA (75 ng/ml
and 0.1% DMSO) . Arrows identify nuclei which in control cultures
are aligned along the longitudinal axes of the myotubes and in
treated cultures are aggregated in the center of the myosacs.
nonmuscle actin (0-actin) and the constitutively expressed
glycolytic enzyme, GAPDH, remain unperturbed or even
slightly increased after the addition of PMA .
PMA Inhibits the Transcription ofSome but NotAll
Skeletal Muscle-specific Genes
To examine the level ofregulation at which PMA exerted its
selective influence over muscle-specific mRNA accumula-
tion, we examined its effects on the transcription of muscle-
specific and nonmuscle genes. Nuclear transcription run-on
assays were conducted to measure the synthesis of nascent
RNAtranscripts in 5-d-oldmuscle cultures after an 8-h treat-
ment withPMA at 75 ng/ml . A typical dot blot from a single
run-on experiment is shown in Fig. 3 A, while a compilation
of data from at least three independent experiments are
shown in Fig . 3 B. Hybridization of de novo synthesized
"P-labeled RNA transcripts to the specific cDNA se-
quences indicated on the blot showed that transcriptional ini-
tiation at the time nuclear isolation of ß-actin and GAPDH
were not significantly blocked . The transcription of the car-
diac a-actin and troponin C genest, for example, was inhib-
ited by -70 and 80%, respectively, while the transcriptional
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Figure 2. Loss ofmuscle-specificmRNAs in PMA-treated cultured
muscle cells . Autoradiogram of a representative experiment in
which totalRNA fromPMA (TPA)-treated cultures was hybridized
with radiolabeledcDNA probes forthe alkali first fast myosin light
chain (MLC IF), cardiac troponin C (cThC), skeletal a-actin (SK
a-Actin), a-cardiaca-actin (CA a-Actin), 0-cytoplasmic actin (0-Ac-
tin), and glyceraldehyde phosphate dehydrogenase (GAPDH).
(PMA [TPA], final concentration of 75 ng/ml and 0.01% DMSO)
was added to 100-120-h cultures ofED 12 chicken pectoral muscle
for the times indicated and total RNA from the cultures was then
harvested as described in Materials and Methods .
activity of other muscle genes (e.g ., skeletal a-actin and fast
MLClf) were not significantly affected .
PMA Destabilizes Muscle ContractileProteinmRNAs
Using pulse-chase kinetic analyses, we next examined
whether the changes inmRNA accumulation were accompa-
nied by changes in mRNA stability. Cellular RNA labeled
748with ['H]uridine was chased with cold uridine and cytidine
and the level of specific mRNAs assayedby hybridization to
denaturedDNAprobes cross-linked to nylon filters . The ki-
netic data for calculating themRNA turnover are presented
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Figure3 . The effect ofPMAon mus-
cle gene transcription . (A) Autoradio-
gram of a representative dot blot of
run-on transcription in nuclei isolated
from control andPMA (TPA)-treated
(75 ng/ml for 8 h) muscle cell cul-
tures. cDNA and PCRprobes corre-
sponding to the genes examined were
bound to Nylon and then hybridized
with radiolabeled in vitro run-on tran-
scripts . The blot was then treated as
described in Materials and Methods.
A parallel autoradiogram in which
the maximum OD A5Q < 1.5 was
analyzed by densitometry. The num-
berbelow each dot is the optical den-
sity of the radiographic image nor-
malized to size of the probe used to
detect the run-on transcripts. (B) Bar
graph analysis ofdensitometric mea-
surements from several independent
experiments . The effects of PMA
(TPA) on transcription of each gene
are expressed as apercentage ofcon-
trol . Error bars indicateone standard
deviation from the mean . (* * *) in-
dicates values that are significantly
different from control (p > 0.001).
in Fig . 4 and the calculated mRNA half lives in Table I . In
untreated cultures, the fastMLClfmRNA wasthe most sta-
ble of all themRNAs examined with acalculated t,n >60 h.
Skeletal a-actin, cardiac a-actin, andcardiac troponin Chad
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normal mRNA half-lives of 19.4, 13.5, and 14.7 h, respec-
tively, whilethe nonmuscle 0-actin and GAPDHmRNAdis-
played relatively short half-lives of 8.4 and 10.7 h, respec-
tively.
Compared with the normaldecay ofthe mRNA molecules,
PMA shortened the half-life of all the muscle-specific
mRNAs. The most dramatic effect of PMA on mRNA turn-
over was observed for fast MLClf with its half-life reduced
from >60 h to -5 h with PMA. This rate, however, was not
achieved until 10-12 h after the addition of PMA. The de-
crease in mRNAhalf-lives for the sarcomericactins and car-
diac ThC, on the other hand, was achieved within 1-3 h after
adding PMA. PMA reduced the half-lives of all three thin
filament mRNAs to a similar level (4.9-5.7 h), but had no
effect on the stability of either 0-actin or GAPDH mRNAs.
TableI. Half-Lives ofMuscle andNonmuscle mRNAs in
Primary Muscle Cell Cultures Treated with PMA
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* Values expressed are the mean f standard deviation of the mean. At least
three separate determinations were done for each measurement.
C B-ACTIN
F GAPDH
Figure 4. Analysis of mRNA turnover in
PMAtreated cultures. Decayof [3H]uri-
dine-labeled mRNAs after an extended
chase after the addition of PMA/DMSO
(TPA) or DMSO alone (control) . Total
RNA was radiolabeled by incubating
cultures for 48 h in ['H]uridine as de-
scribed in Materials and Methods. Ra-
diolabeled uridine was then removed
and the cultures "chased" for 4 hours
with unlabeled uridine and cytidine.
PMA or vehicle (DMSO) was then
addedand cultures were then harvested
at the times indicated. RNA was isolated
from the cultures and hybridized to
cDNA and PCR probes that were immo-
bilized on Nylon membranes. The level
ofspecific mRNAwas quantitated either
by densitometry of the blots after fluo-
rography or by scintillation counting of
eluted radiolabeled RNA boundto dena-
turedcDNA or PCRprobes immobilized
on Nylon. All values are expressed rela-
tive to the value at the beginning of TPA
addition. All datapoints represent the
mean of three independent determina-
tions with the standard error of that
12
￿
24
￿
mean contained within the area of the
Hours after chase
￿
symbols.
12 24
Hoursafter chase
The Accelerated TurnoverofmRNA in PMA-treated
Myotubes Is Blocked by Transcription Inhibitors
Attempts to measuremRNAstability by monitoringtotal ac-
cumulation after inhibiting RNA synthesis were unsuccess-
ful since such inhibitors appeared to actually block the de-
crease in mRNA accumulation that occurred after PMA
addition. This effect is illustrated in Fig. 5, which shows a
typical experimentin which the RNA transcription inhibitor,
5,6-dichloro-l-D-ribobenzimidazole (DRB, 60 AM), was ap-
plied alone or in combination with 75 ng/ml PMA to cultured
muscle cells. Total cellular RNA isolated from myotubes
during an 18-h time course was then probed for skeletal
a-actin, MLClf, and 0-actin mRNA levels. As before, PMA
caused an extensive decrease in both MLClf and skeletal
a-actin mRNA accumulation after 18 h of exposure. For
both muscle genes, DRB resulted in an unexpected increase
in mRNA levels in both control and PMA-treated cultures.
This increase in PMA-treated cultures was large enough to
suggest that DRB blocked the action ofPMA. As before, the
level of 0-actin mRNA accumulation was not changed by
PMA. DRB alone or in combination with PMA resulted in
a significant reduction in 0-actin mRNA levels, probably
reflectingthe decay of mRNA after DRB's inhibition of 0-ac-
tin transcription.
Similar results were obtained with other transcriptional
inhibitors, such as actinomycin D (10 Ag/ml), although the
effects of transcriptional inhibition were not as reversible as
with DRB. In addition, the decrease in MLClf levels after
PMA administration was also blocked by coadministration
of the translation inhibitor, cycloheximide, at doses that in-
hibited protein synthesis by >90% (10 AM).
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mRNA
Half-lives
Control PMA
h
Skeletal ci-actin 19.4 f 2.4* 4.9 t 0.7
Cardiac ot-actin 13.5 f 1.6 5.7 f 0.6
0-actin 8.4 f 1.1 8.6 t 1.2
MLClf >60 4.8 t 0.5
Cardiac TN C 14.7 t 1.2 5.1 f 0.4
GAPDH 10.7 f 1.4 10.5 t 1.7Figure 5. An RNA transcription inhibitor blocks PMAs effect on
mRNA stability. Northern blot analyses of RNA from cultures
treated with DRB, TPA (PMA), and DRB/TPA and hybridized
with radiolabeled cDNA probes to MLCIf, skeletal a-actin, and
/3-actin. PMA (75 ng/ml in DMSO) and 5,6-dichloro-l-D-ribobenz-
imidazole (DRB, 5 fig/nil) were added to 100-120-h cultures ofED
12 chicken pectoral muscle alone or in combination and total RNA
from the cultures was harvested after 18 h.
PKCIs Depleted in PMA-treatedCultured Chicken
Muscle Cells
In many cell types, the principalmechanism ofphorbol ester
action is to bind to the regulatory domain of the calcium-
phospholipid-dependent PKCs in the cell and to alter their
activity. Such binding initially leads to PKC activation, but
continued interaction results in decreased activity as PKC
protein levels are downregulated (Ballester and Rosen, 1985 ;
Hepler et al., 1988) . The kinetics of this effect depends on
the concentration ofphorbol ester and the cell type to which
it is administered . To determine what effect PMA is having
on PKC content in the chicken muscle cell cultures over the
time course of our experiments, we measured the relative
levels ofPKC in control and PMA-treated cultures by phor-
bol 12,13-dibutyrate (PdBu) binding . The binding character-
istics of the radiolabeled phorbol were firstdeterminedby in-
cubating untreated cells with increasing amounts of the
labeled phorbol ester. Specific binding of the label was
saturable at 1.56 f 0.23 pmol/well or 2 .15 f 0.31 pmol/mg
protein (Fig . 6 A) and a Scatchard analysis ofthe data (inset,
Fig. 6 A) revealed a dissociation binding constant (K d) of
36.4 f 1 .9nM(-20 ng/ml) . While this value is significantly
higher than theK ds reported for many replicating cells, in-
cluding myoblasts, it is similar to that observed for differen-
tiated mammalian muscle cells (Martelly et al ., 1989) .
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Table 11 . PKC Activity in Control and PMA-treated
Chicken Muscle Cell Cultures
Values expressed are the mean f standard deviation ofthe mean . At least three
separate determinations were performed for each measurement .
A saturating dose of the labeled PdBu was then used to ob-
tain a relative measure of PKC levels in cells exposed to
PMA for various times (Fig . 6 B) . Significant reductions in
PdBu binding signaling a downregulation ofPKC levels were
evident as early as 8 h afterPMA addition . After 24 h, <5° lo
ofthe binding activity detected in untreated parallel controls
could be seen in the muscle cells. Therefore, over the period
during which contractile protein mRNAs were being selec-
tively depleted from the cells, PdBu binding to PKC was
significantly reduced . If, as in other cell types, changes in
PdBu binding reflect changes in the amount ofintactPKC en-
zyme, total activatable enzyme would be reduced to such
low levels that, even if it were fully active in vivo, PKC activ-
ity would be significantly reduced at the earliest times after
PMA addition .
To corroborate these findings, PKC activity in both soluble
and particulate cell fractions was also measured (Table II) .
Total activatable enzyme is presented as the sum ofenzyme
activity in both subcellular compartments, while estimated
in vivo activity is represented by that in the particulate
(membrane) fraction . The results presented in Table H show
a substantial decrease in the total activatable pool ofPKC
in PMA-treated cultures that parallels the reduction in phor-
bol ester binding seen in Fig. 6 B.
Discussion
PMA at doses identical to those used in this study have been
shown by others to cause a selective disassembly of the sar-
comeric structures in primary cultures of avian embryonic
muscle and the subsequent degradation oftheir protein con-
stituents (Lin et al ., 1987, 1989) . We demonstrate here that
these morphological and protein biochemical changes are
also accompanied by dramatic reductions in the accumula-
tion ofmRNAs encoding the contractile proteins and that
this reduction is selective for the mRNAs encoding the con-
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PKC Activities
(1)
soluble
(2)
particulate
(1 + 2)
total
pmol/minlmg protein
T=0
Control 27.9 2.5 59.4 6 .1 87.3 8.1
T=8h
Control 31 .2 3.7 61 .5 4.5 92.7 8.4
PMA 3.511.3 27.4 1 .9 30.9 3.0
T= 16h
Control 31 .7 2.6 52 .6 4.6 82.3 7 .1
PMA 2 .1 1 1.2 13 .4 1 2.3 15.5 1 3.2
T=24h
Control 22.3 1 .8 56.8 4.5 79 .1 5 .9
PMA 1 .8 1 0.8 6.3 1 1 .2 8 .1 1 1 .8
T=48h
Control 23.7 2.1 64.6 3.6 88.3 5 .4
PMA 0.6 1 0.4 2.4 1 1 .3 3.0 1 1 .4Figure 6 . Analysis of phorbol binding to cultured chicken muscle
cells . (A) Saturation curve for PH]phorbol 12,13-dibutyrate bind-
ing to cultured chicken muscle cells . Binding is expressed as pico-
moles bound per milliliter extract and as picomoles per milligram
protein extract in the Scatchard analysis shown in the inset . Data
represent three independent determinations . Standard error of the
mean for each datapoint in within the area of the symbol . (B)
Effects of preincubation of cells with PMA for the times indicated
on saturable phorbol dibutyrate binding. Cells were incubated with
200nM ['H]PdBu and specific binding determined as described in
Materials and Methods. The values for treated and parallel control
cultures are expressed relative to the binding values determined at
the zero timepoint for the experiment .
tractile proteins . The steady-state levels of different mRNÁs
reflect the balance between the rate of synthesis of new
mRNAs and the rate ofmRNA degradation . Pulse-chase ki-
netic analyses indicated thatPMA treatment of differentiated
muscle cells resulted in a dramatic destabilization of all the
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contractile protein mRNAs examined . Nuclear run-on as-
says indicated that expression of the cardiac a-actin and
troponin C genes was also inhibited at the transcriptional
level by 70-80 %, while skeletal a-actin, fastMLClf, and the
nonmuscle ß-actin andGAPDH genes were not significantly
effected . It has previously been shown that the cardiac and
skeletal a-actin genes are expressed in a sequential manner
during muscle development (Hayward and Schwartz, 1986)
and that skeletal a-actin but not cardiac a-actin gene expres-
sion can be selectively blocked by reducing extracellular cal-
cium (Hayward et al., 1988) . The results presented here on
the differential effect of PMA on transcription of these iso-
forms reveals another fundamental difference in the way
these sarcomeric a-actin genes are regulated .
The changes observed inmRNA accumulation uponPMA
addition (Fig . 2) are consistent with the effects of this drug
on the transcription of the muscle genes and the stability of
theirmRNAproducts . Inthe case ofboth cardiac a-actin and
troponin C, mRNA levels fell the quickest and remained the
lowest, an outcome predicted by the fact that transcription
of these genes was virtually shutdown by PMA and that the
stability of the existing mRNA markedly decreased . The
transcription ofthe skeletal a-actin andMLClfgenes, on the
other hand, were relatively unaffected by PMA . ThemRNA
content of these genes fell to levels of accumulation of
-25% for skeletal a-actin genes and 5-10% for MLClf,
these changes reflecting solely the reduction in mRNA half-
life by PMA . Poly A+ RNAs from muscle cell cultures
were previously shown to be distributed into two populations
with regard to their stability. Medford et al . (1983) showed
that one RNA population had a t- h <4 h and the other a t- h
which ranged from 17 to >54 h, with muscle-specific pro-
teins apparently encoded by the longer-lived mRNAs (Buck-
ingham et al ., 1976 ; Medford et al., 1983) . We found that
the t-- A of primary muscle cell culture mRNÀs was parti-
tioned in a similar manner, in which the muscle-specific
mRNAs were the most stable and the nonmuscle mRNAs
among the least stable (Table I) . PMA dramatically reduced
the stability ofall the muscle-specific mRNAs tested to level
that was similar to that of the nonmuscle-specific mRNAs
(e.g., -5 h) . The stability of the nonmyogenic mRNAs re-
main unchanged by PMA .
The method used to estimate the stability of specific
mRNÁs relied on labeling the mRNA pool and then follow-
ing the loss oflabel from that pool . This method may fail to
give a truly accurate measurement of degradation rates be-
cause the specific activity of the labeled mRNA pool is con-
tinually being reduced as newly synthesized mRNA tran-
scripts are added to the pool . For most of the mRNAs
studied, however, this method gives a reasonable measure-
ment of the relative differences between the control and
treated states, because the error contributed by transcription
is the same for both control and treated cultures . But since
the transcription of both the cardiac a-actin and cardiac
troponin C genes are significantly reduced by PMA, this
method underestimates the relative difference between the
degradation rates in control and treated cultures, sincePMA
inhibits the transcription of these genes . If for the sake ofar-
gument, we imagine thatPMA had no effect on the stability
of either cardiac actin or troponin C mRNAs, then at any
given time after labeling and during the chase, the specific
activity of label in the mRNA pool of control cultures will
752be less than that in the PMA-treated cultures because of the
differential contribution of newly synthesized transcripts in
the control cultures. Over time, the specific activity of the
control culture would decrease and it would appear that
PMA decreased the rate of degradation and stabilized the
mRNA . To compare the decay rates in treated and untreated
cultures, an adjustment must be applied to the data to com-
pensate forthis artifact. In the case ofthe mRNAs for cardiac
actin and troponin C, the difference in decay rates between
control and PMA-treated cultures and the effect of PMA on
destabilizing these mRNAs is even greater than we measure.
While such adjustments were not applied to the data shown
in Fig. 4 and Table I, they would only serve to strengthen
the conclusions concerning the destabilization of these
cardiac isoform mRNAs relative to control values and not to
negate or weaken them.
The selective turnover of the striated ci-actin mRNAs
versus the nonmuscle ß-actin shows for the first time that se-
quence differences between these evolutionarily conserved
actin mRNA isoforms may have a role in determining their
intrinsic half-lifes and cellular content. Comparison of the
untranslatedregions in vertebrate skeletala-, cardiac a-, and
0-actin mRNA has revealed regions ofhigh sequence homol-
ogy within the 3' portion of each of these actin isoformic
mRNAs and that this homology is greater among the a-stri-
ated isoforms than between the a- and ß-isoforms (Mayer
et al., 1984; Ponteet al., 1984; Chang et al., 1985) . In com-
parison, other vertebrate genes such as those encoding insu-
lin (Lomedico, 1979) and prolactin (Cooke et al ., 1981),
which also share common coding regions usually contain
divergent 3' untranslated regions. The preservation of the 3'
untranslated regions for over 300 million years of evolution
suggests that they have important biological roles for the ex-
pression ofthe actin genes and the results presented here im-
plicate these at the level of mRNA stability.
Since transcription inhibitors blocked the PMA-induced
changes in muscle-specific mRNA turnover (Fig. 5), the in-
duction of de novo transcripts by PMA may play an impor-
tant role in the accelerated turnover of these mRNAs. The
fact that the protein synthesis inhibitor, cycloheximide, also
prevented the PMA-induced destabilization of muscle-spe-
cific mRNAs (unpublished observation) suggests that the
transcripts are translated into proteins with relatively short
half-lifes. A similar requirement for protein synthesis to ob-
serve the other effects of PMA on differentiative properties
in muscle has been described previously (Cossu et al.,
1982). These proteins could be directly involved in the
destabilization process as has been shown for c-myc, in
which a labile protein destabilizer with an essential nucleic
acid component was recently identified (Brewer and Ross,
1989) . On the other hand, it is possible that all these inhibi-
tors alter the ability of the cells to respond to PMA. How-
ever, cells treated with these inhibitors and then exposed to
PMA still exhibit many of the morphological changes that
are visible at the lightmicroscopic level and that occur in un-
treated cells in response to PMA (unpublished observa-
tions). These include the deposition of muscle nuclei into a
centralized region of the myotube and the loss of elongated
structure to form a myosac. Experiments are underway to de-
termine if the immunochemical changes that have been de-
scribed in PMA treated cells also occur in DRB and CHD-
treated cells in response to PMA.
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The primary mode of phorbol ester action in many ex-
perimentalsystems is to bind to and alterPKC activity. Criti-
cal to the interpretation of the results presented here is what
effect PMA may have on PKC level and activity throughout
the period of sarcomere disassembly and message loss.
While PMA has activated PKC, it can provide a dual effect
on PKC activity, causing first a short-term activation and
then an inhibition as a result of the degradation of the mole-
cule (Ballester and Rosen, 1985 ; Hepler et al., 1988). At the
dosesused in this study and the time at which its effects were
assayed, PMA is acting to inhibit PKC levels and activity
(Fig. 6 and Table II). Consistent with the fact that the effects
we have observed are correlated with PKC inhibition and
not activation is that treatment of the cells with known PKC
activators, such as the permeable diacylglycerol analogues
oleoyl-acetyl-sn-glycerol and dioctanoylglycerol, slightly ele-
vated muscle specific mRNAs rather than decreasing them,
while inhibitors of protein kinase C, such as staurosporine
and H7 [1-(5-isoquinolinesulfonyl)-2-methylpiperazine di-
hydrochloride], decreased expression of skeletal a-actin
mRNA, while not affecting 0-actin expression (data not
shown). While both staurosporine and H7 can have inhibitory
effects on other protein kinases (Tamaoki et al ., 1986; Love
et al., 1989), the common specificity of these drugs toward
PKC suggests that the observed effects on contractile protein
mRNA content might be, in part, due to PKC inhibition.
PMA-induced disassembly of striated myofibrils was
shown by Holtzer and collaborators (Lin et al., 1987, 1989)
to be a multistep process in which I-Z-I complexes contain-
ing a-sarcomeric actins (I) and a-actinin (Z) were selec-
tively released from the myofibrils within 5-10 h to form 3
IM cortical actin-containing bodies (CABs). The myosin-
containing A bands were then disrupted only after 15-20 h
in PMA. At the protein level, immunologically detected cel-
lular a-actin was lost after 30 h of treatment, while MHC-
staining amorphous patches were evident up to 72 h. Our
data on the temporal pattern of muscle specific contractile
mRNAs reduction displays a striking consistency with this
temporal order of sarcomere disassembly. The mRNAs en-
coding a-cardiac actin, a skeletal actin, and cardiac tropo-
nin C, all thin filament (I band) proteins, are significantly re-
duced after only 5 h of treatment. MLClf, a thick filament
(A band) component, on the other hand, declined at a slower
rate consistent with the slower disappearance of A-band as-
sociated proteins. Kinetic analysis of this disappearance
identifies two components to the apparent slower rate of
loss: (a) a delay of -10 h after PMA addition during which
MLCIf mRNA decayed at a nonlinear rate, followed by
(b) a linear rate of decay similar to that of the mRNA for
the thin filament proteins. This delay in degradation of the
MLClf mRNA is consistent with the hypothesis that the
destabilization of the contractile protein mRNAs is an event
secondary to the loss of sarcomeric structure and the degra-
dation ofthe contractile apparatus rather than a consequence
of a separate intracellular catabolic pathway activated by
phorbol esters. If the stability of the contractile proteins
were, in turn, dependent on their assembly into contractile
structures, the stability of contractile protein mRNAs would
then be determined by the stability of their encoded gene
products.
Finally, the selective transcriptional effect of PMA on
cardiac a-actin and troponin C genes is particularly intrigu-
753ing in light of the regulation of these genes in ovo . The
cardiac and skeletal ci-actin genes are expressed in a specific
manner during muscle development (Hayward and Schwartz,
1986) with the cardiac isoform being the predominant spe-
cies expressed in early embryonic development ofthe chick .
The transition from early to late embryonic expression is
then marked by the downregulation of cardiac-type isoforms
and the upregulation of their skeletal-type counterparts . The
response of cultured muscle cells to PMA mimics one part
of the molecular events associated with this developmental
transition (i.e., the downregulation of early embryonic car-
diac-type isoform expression) and implicate changes inPKC
as a possible intracellular messenger finking extracellular sig-
nals and developmental gene expression (Papadopoulos and
Crow, 1991) . Careful studies ofhow cells respond to changes
in PKC and particular PKC isozymes may provide insight
into how muscle cells regulate isoform-specific expression
from gene families during development and in various physi-
ological and pathophysiological circumstances .
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